|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45,400.00 KRW | -6.20% |
|
-6.78% | -62.17% |
| 07-15 | Alert wrongly tagged to Orum Therapeutics withdrawn | RE |
| 04-17 | Orum Therapeutics Presents New Preclinical Data on ORM-1153, A CD123-Targeting Degrader-Antibody Conjugate | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.20% | -6.78% | -35.14% | -47.15% | -62.17% | +99.56% | - | - | - | 666M | |
| -7.17% | -4.39% | +20.05% | +18.61% | +30.06% | +45.51% | +79.00% | -28.59% | - | 55.98B | |
| +0.24% | -1.54% | -3.61% | +4.76% | +4.91% | +53.22% | +71.85% | +190.35% | +5,511.94% | 53.69B | |
| +0.80% | -6.31% | +10.03% | -25.03% | -37.76% | +3.98% | +423.29% | +306.30% | +850.18% | 23.29B | |
| -0.09% | -0.01% | -0.80% | -11.12% | -3.91% | -17.62% | -14.67% | -60.48% | - | 23.15B | |
| -5.95% | -2.58% | +23.84% | +3.53% | +17.62% | +30.67% | -9.58% | -73.57% | - | 20.58B | |
| -1.14% | +0.03% | +14.10% | +3.60% | -7.79% | +31.57% | -30.42% | -31.46% | +63.66% | 17.76B | |
| -5.16% | -7.00% | +31.25% | +103.00% | +182.04% | +168.44% | +306.37% | +1,565.96% | +592.91% | 16.09B | |
| -6.91% | -5.83% | +20.58% | -6.46% | +24.02% | +26.53% | +636.97% | - | - | 15.93B | |
| +0.43% | -1.03% | +6.64% | +24.57% | +27.58% | +24.63% | +191.40% | +232.86% | +562.56% | 14B | |
| +1.46% | +3.13% | +10.73% | +4.03% | -4.96% | +58.71% | +148.16% | +489.62% | - | 12.58B | |
| -13.21% | -9.15% | +5.30% | -41.49% | -21.81% | -36.67% | +138.14% | +52.20% | - | 11.96B | |
| +0.36% | -9.44% | -1.85% | -45.09% | -21.04% | -50.02% | +542.33% | +95.06% | +82.92% | 10.68B | |
| -0.22% | -5.53% | +2.65% | +20.19% | +26.19% | +106.17% | +137.15% | +316.95% | +710.72% | 10.91B | |
| +4.10% | -2.75% | -8.32% | +6.89% | +11.91% | +294.16% | +114.12% | +17.14% | +1,178.83% | 10.05B | |
| -10.29% | -9.33% | +13.13% | -36.41% | +5.90% | +10.59% | +75.89% | -28.80% | - | 9.42B | |
| +6.49% | +2.55% | +14.56% | +37.28% | +205.95% | +493.43% | +568.20% | -40.78% | -11.30% | 8.28B | |
| -0.06% | +0.34% | +134.57% | +104.54% | +80.15% | +153.97% | +320.14% | +325.25% | - | 8.85B | |
| -7.57% | -6.70% | +38.09% | +17.54% | +10.13% | +15.85% | +299.79% | +270.00% | - | 8.24B | |
| +0.29% | -3.45% | +10.91% | -9.86% | +21.80% | +50.39% | +17.92% | +161.40% | - | 8.09B | |
| Average | -2.49% | -0.86% | +15.34% | +6.30% | +24.44% | +78.15% | +211.37% | +208.86% | +1,060.27% | 17.01B | |
| Weighted average by Cap. | -2.67% | -0.74% | +13.95% | +8.17% | +21.88% | +58.17% | +169.74% | +179.12% | +2,152.87% |
- Stock Market
- Stocks
- A475830 Stock
- Sector Orum Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
